GlaxoSmithKline's approval streak helps ease scandal pain

GlaxoSmithKline ($GSK) has been having a year for the record book. And that's not entirely a good thing. Report

Launch Readiness

Optimize cross-functional collaboration and engage with key stakeholders for the successful launch of a product

Join the Launch Readiness for Medical Affairs & Communications Teams Summit to learn best practices in taking a structured approach to enhance medical affairs activities surrounding a launch and increase knowledge and communication with thought leaders.